16-51137124-G-C
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2
The NM_002968.3(SALL1):c.3963C>G(p.Ile1321Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,614,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. I1321I) has been classified as Likely benign.
Frequency
Consequence
NM_002968.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152140Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251430 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461860Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727232 show subpopulations
GnomAD4 genome AF: 0.000190 AC: 29AN: 152258Hom.: 0 Cov.: 31 AF XY: 0.000228 AC XY: 17AN XY: 74436 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.3963C>G (p.I1321M) alteration is located in exon 3 (coding exon 3) of the SALL1 gene. This alteration results from a C to G substitution at nucleotide position 3963, causing the isoleucine (I) at amino acid position 1321 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at